BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32285478)

  • 1. Pharmacokinetic interaction between a Chinese herbal formula Huosu Yangwei oral liquid and apatinib in vitro and in vivo.
    Fang SQ; Huang J; Zhang F; Ni HM; Chen QL; Zhu JR; Fu ZC; Zhu L; Hao WW; Ge GB
    J Pharm Pharmacol; 2020 Jul; 72(7):979-989. PubMed ID: 32285478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
    Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
    Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional profiling and network pharmacology analysis identify the potential biomarkers from Chinese herbal formula Huosu Yangwei Formula treated gastric cancer in vivo.
    Fang SQ; Liu YH; Zhao KP; Zhang HX; Wang HW; Deng YH; Zhou YX; Ge GB; Ni HM; Chen QL
    Chin J Nat Med; 2021 Dec; 19(12):944-953. PubMed ID: 34961592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics and systems network-based molecular mechanism of herbal formula Huosu-Yangwei inhibited gastric cancer in vivo.
    Zhang M; Ding Y; Hu S; Li F; Wang Y; Zhou Y; Qi M; Ni H; Fang S; Chen Q
    J Ethnopharmacol; 2023 Nov; 316():116674. PubMed ID: 37277085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP- glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes.
    Shi X; Zhang G; Mackie B; Yang S; Wang J; Shan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():145-156. PubMed ID: 27428458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
    Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
    Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the inhibition effects of apatinib on human and rat cytochrome P450.
    Bao SS; Wen J; Zheng X; Zhou Q; Qu GE; Chen MJ; Hu GX
    Toxicol Lett; 2018 Nov; 297():1-7. PubMed ID: 30138636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of apatinib on pharmacokinetic profile of buspirone both in vivo and in vitro.
    Zhang XD; Li YH; Chen DX; You WW; Hu XX; Chen BB; Hu GX; Qian JC
    J Pharm Pharmacol; 2020 Oct; 72(10):1405-1411. PubMed ID: 32608074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
    Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
    Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
    Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
    Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates.
    Liu LY; Han YL; Zhu JH; Yu Q; Yang QJ; Lu J; Guo C
    Biomed Chromatogr; 2015 Mar; 29(3):437-44. PubMed ID: 25098274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
    Wang B; Yang S; Hu J; Li Y
    J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
    Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
    Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
    Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of isocorynoxeine metabolites mediated by cytochrome P450 enzymes in rat and human liver microsomes.
    Zhao L; Zang B; Qi W; Chen F; Wang H; Kano Y; Yuan D
    Fitoterapia; 2016 Jun; 111():49-57. PubMed ID: 27094112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human.
    Ma XC; Ning J; Ge GB; Liang SC; Wang XL; Zhang BJ; Huang SS; Li JK; Yang L
    Drug Metab Dispos; 2011 Apr; 39(4):675-82. PubMed ID: 21205911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.